ARCHIVES

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Owens Becomes President, NCCR

June 21, 1996

Screening Guidelines Differ Among Major Medical Organizations

January 16, 1998

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

February 24, 2012

DeVita Losing Patience, Responds To Powers Letter

May 6, 1983

CCOP RFA On The Street; Addition Of Cancer Control Research Adds New Dimension To Program

July 18, 1986